Epigenetic silencing of BRCA1 gene associated with demographic and pathologic factors in sporadic breast cancer: A study of an Indian population

European Journal of Cancer Prevention

Volumn 20, Issue 6, 2011, Pages 478-483

  Singh, Alok Kumar ^a   Pandey, Anjita ^b   Tewari, Mallika ^b   Shukla, Hari Shankar ^b   Pandey, Hausila Prasad ^c  

^a AMITY UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

^c BANARAS HINDU UNIVERSITY   (India)

Author keywords

BRCA1; breast cancer; epigenetic; metastasis; promoter methylation

Indexed keywords

BRCA1 PROTEIN; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER STAGING; CONTROLLED STUDY; CORRELATIONAL STUDY; DEMOGRAPHY; DNA METHYLATION; DNA REPAIR; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; INDIA; MAJOR CLINICAL STUDY; ONCOGENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PREMENOPAUSE; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; DNA METHYLATION; EPIGENOMICS; FEMALE; GENE SILENCING; GENES, BRCA1; HUMANS; INDIA; MIDDLE AGED; POPULATION SURVEILLANCE; PROMOTER REGIONS, GENETIC;

EID: 80053632512     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32834761a6     Document Type: Article

References (31)

1. Agrawal A, Murphy RF, Agrawal DK (2007). DNA methylation in breast and colorectal cancers. Mod Pathol 20:711-721. (Pubitemid 46933450)
2. Bae YK, Brown A, Garrett E, Bornman D, Fackler MJ, Sukumar S, et al. (2004). Hypermethylation in histologically distinct classes of breast cancer. Clinical Cancer Res 10 (18 Pt 1):5998-6005. (Pubitemid 39287504)
3. Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY (2000). BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. Cancer Res 60:5329-5333.
4. Birgisdottir V, Stefansson OA, Bodvarsdottir SK, Hilmarsdottir H, Jonasson JG, Eyfjord JE (2006). Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Res 8:R38.
5. Brown MA, Xu CF, Nicolai H, Griffiths B, Chambers JA, Black D, Solomon E (1996). The 59 end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. Oncogene 12:2507-2513. (Pubitemid 26237779)
6. Catteau A, Morris JR (2002). BRCA1 methylation: a significant role in tumour development? Semin Cancer Biol 12:359-371.
7. Clark SJ (2007). Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis. Hum Mol Genet 16:R88-R95. (Pubitemid 47241847)
8. Clark SJ, Harrison J, Paul CL, Frommer M (1994). High sensitivity mapping of methylated cytosines. Nucleic Acids Res 22:2990-2997. (Pubitemid 24260626)
9. Esteller M (2000). Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes. Eur J Cancer 36:2294-2300.
10. Esteller M, Silva JM, Dominguez G, Garcia-foncillas J, Hedenfalk I, Godwin AK, et al. (2000). Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92:564-569. (Pubitemid 30212318)
11. Esteller M, Fraga MF, Guo M, Bonilla F, Matias-Guiu X, Bussaglia E, et al. (2001). DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet 10:3001-3007. (Pubitemid 34083486)
12. Fiegl H, Millinger S, Mueller-Holzner E, Marth C, Ensinger C, Berger A, et al. (2005). Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients. Cancer Res 65:1141-1145. (Pubitemid 40270136)
13. Georgiou E, Valeri R, Tzimagiorgis G, Anzel J, Krikelis D, Tsilikas C, et al. (2007). Aberrant p16 promoter methylation among Greek lung cancer patients and smokers: correlation with smoking. Eur J Cancer Prev 16:396-402. (Pubitemid 47549998)
14. Grushko TA, Olopade OI (2004). Genetic markers in breast tumors with hereditary predisposition. In: Bronchud MH, Foote MA, Giaconne G, Olopade OI, Workman P, editors. Principles of molecular oncology. 2nd ed. Totowa (NJ): Humana Press; pp. 151-180.
15. Grushko TA, Blackwood MA, Schumm PL, Hagos FG, Adeyanju MO, Feldman MD, et al. (2002). Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers. Cancer Res 62:1481-1488. (Pubitemid 34407811)
16. Jones PA, Baylin SB (2002). The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428. (Pubitemid 34587077)
17. Kim SJ, Kang HS, Chang HL, Jung YC, Sim HB, Lee KS, et al. (2008). Promoter hypomethylation of the N-acetyltransferase 1 gene in breast cancer. Oncol Rep 19:663-668. (Pubitemid 351330433)
18. Mirza S, Sharma G, Prasad CP, Parshad R, Srivastava A, Gupta SD, Ralhan R (2007). Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Life Sci 81:280-287. (Pubitemid 47030571)
19. Muller HM, Widschwendter A, Fiegl H, Ivarsson L, Goebel G, Perkmann E, et al. (2003). DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res 63:7641-7645. (Pubitemid 37466689)
20. Pandey A, Singh AK, Maurya SK, Rai R, Tewari M, Kumar M, Shukla HS (2009). Genomic profiling of breast cancer. J Surg Oncol 99:386-392.
21. Rosen EM, Fan S, Pestell RG, Goldberg ID (2003). BRCA1 gene in breast cancer. J Cell Physiol 196:19-41. (Pubitemid 36676440)
22. Sharma G, Mirza S, Prasad CP, Srivastava A, Gupta SD, Ralhan R (2007). Promoter hypermethylation of p16(INK4A), p14(ARF), CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Life Sci 80:1873-1881. (Pubitemid 46562520)
23. Shukla S, Mirza S, Sharma G, Parshad R, Gupta SD, Ralhan R (2006). Detection of RASSF1A and RAR beta hypermethylation in serum DNA from breast cancer patients. Epigenetics 1:88-93.
24. Staff S, Isola J, Tanner M (2003). Haplo-insufficiency of BRCA1 in sporadic breast cancer. Cancer Res 63:4978-4983. (Pubitemid 37022634)
25. Stein R, Gruenbaum Y, Pollack Y, Razin A, Cedar H (1982). Clonal inheritance of the pattern of DNA methylation in mouse cells. Proc Natl Acad Sci 79:61-65. (Pubitemid 12181486)
26. Suijkerbuijk KPM, Fackler MJ, Sukumar S, Van Gils CH, Van Laar T, Van Der Wall E, et al. (2008). Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer. Annals of Oncology 19:1870-1874.
27. Turner N, Tutt A, Ashworth A (2005). Targeting the DNA repair defect of BRCA tumours. Curr Opin Pharmacol 5:388-393. (Pubitemid 40932041)
28. Wei M, Grushko TA, Dignam J, Hagos F, Nanda R, Sveen L, et al. (2005). BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. Cancer Res 65:10692-10699. (Pubitemid 41713336)
29. Widschwendter M, Jones PA (2002). DNA methylation and breast carcinogen-esis. Oncogene 21:5462-5482.
30. Xu CF, Chambers JA, Solomon E (1997). Complex regulation of the BRCA1 gene. J Biol Chem 272:20994-20997. (Pubitemid 27373954)
31. Xu X, Gammon MD, Zhang Y, Bestor TH, Zeisel SH, Wetmur JG, et al. (2008). BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat 115:397-404.